Audit 174113

FY End
2022-12-31
Total Expended
$22.63M
Findings
0
Programs
8
Year: 2022 Accepted: 2023-09-28

Organization Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
D41LDEATDV49 Laura Schilare Auditee
7322947050 David Wiessel Auditor
No contacts on file

Notes to SEFA

Title: COVID-19 Disaster Grants Public Assistance (Presidentially Declared Dis Accounting Policies: The accompanying Schedules of Expenditures of Federal and State awards (the Schedules) include the federal and state grant activity of CentraState Healthcare System, Inc. (the System) for the year ended December 31, 2022, recorded on the accrual basis of accounting. The information in the Schedules is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance) and New Jersey OMB Circular Letter 15-08-OMB, Single Audit Policy for Recipients of Federal Grants, State Grants and State Aid (Circular Letter 15-08-OMB). In accordance with applicable requirements, certain programs may be presented in a fiscal period based on the program-specific guidance (see Notes 2 and 3). Therefore, some amounts presented in the Schedules may differ from amounts presented in, or used in the preparation of, the Systems consolidated financial statements. For purposes of the Schedules, federal and state awards include any assistance provided by a federal and state agency directly or indirectly in the form of grants, contracts, cooperative agreements, loans and loan guarantees, or other non-cash assistance. Federally funded amounts that are passed through state agencies are included on the schedule of expenditures of federal awards and are excluded from the schedule of expenditures of state awards. De Minimis Rate Used: N Rate Explanation: The Uniform Guidance provides for a 10% de minimis indirect cost rate election; however, the System did not make this election and uses a negotiated indirect cost rate. The System incurred certain expenditures related to the Coronavirus Disease 2019 (COVID-19) pandemic which are eligible for reimbursement from the Federal Emergency Management Agency (FEMA) Disaster Grants Public Assistance (Presidentially Declared Disasters) (Assistance Listing No. 97.036). The System has applied for and received approval for reimbursement of qualifying expenses totaling $15.8 million from FEMA, including $15.7 million of expenditures that were incurred in previous periods and approved by FEMA in 2022. This amount has been included in the accompanying schedule of expenditures of federal awards for the year ended December 31, 2022 in accordance with the guidance specific to Assistance Listing No. 97.036. Additional costs have been and are expected to be submitted to FEMA for reimbursement.
Title: COVID-19 - Provider Relief Fund Accounting Policies: The accompanying Schedules of Expenditures of Federal and State awards (the Schedules) include the federal and state grant activity of CentraState Healthcare System, Inc. (the System) for the year ended December 31, 2022, recorded on the accrual basis of accounting. The information in the Schedules is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance) and New Jersey OMB Circular Letter 15-08-OMB, Single Audit Policy for Recipients of Federal Grants, State Grants and State Aid (Circular Letter 15-08-OMB). In accordance with applicable requirements, certain programs may be presented in a fiscal period based on the program-specific guidance (see Notes 2 and 3). Therefore, some amounts presented in the Schedules may differ from amounts presented in, or used in the preparation of, the Systems consolidated financial statements. For purposes of the Schedules, federal and state awards include any assistance provided by a federal and state agency directly or indirectly in the form of grants, contracts, cooperative agreements, loans and loan guarantees, or other non-cash assistance. Federally funded amounts that are passed through state agencies are included on the schedule of expenditures of federal awards and are excluded from the schedule of expenditures of state awards. De Minimis Rate Used: N Rate Explanation: The Uniform Guidance provides for a 10% de minimis indirect cost rate election; however, the System did not make this election and uses a negotiated indirect cost rate. In accordance with the U.S. Department of Health and Human Services requirements specific to Federal Assistance Listing No. 93.498, COVID-19 Provider Relief Fund (PRF), the amount presented on the accompanying schedule of expenditures of federal awards for the year ended December 31, 2022 for Federal Assistance Listing No. 93.498 relates to (i) Provider Relief Fund (PRF) payments received from January 1, 2021 through December 31, 2021 (ii) used for PRF-eligible activity from the period January 1, 2020 through December 31, 2022. This payment receipt period and activity period and the resulting amount presented on the accompanying schedule of expenditures of federal awards for the year ended December 31, 2022 reconciles to the PRF information previously reported to the Health Resources and Services Administration (HRSA) for PRF Reporting Periods 3 and 4 (see financial statements for chart/table). The expenses and lost revenues incurred by the System during the periods of availability through PRF Reporting Period 4 (January 1, 2020 through December 31, 2022) are in excess of the distributions received in PRF Reporting Periods 1 and 2 (which addressed payments received during April 10, 2020 to December 31, 2020, and previously reported on the schedule of expenditures of federal awards for the year ended December 31, 2021) and distributions received in PRF Reporting Periods 3 and 4 (January 1, 2021 through December 31, 2021) and, therefore, the amounts presented in the table above and on the accompanying Schedule are limited to distributions received in PRF Reporting Periods 3 and 4.